Smith & Nephew bolsters repless Syncera program May 6, 2015 By Brad Perriello Leave a Comment Smith & Nephew (NYSE:SNN) added a pair of software assets to its Syncera generic sales business, a so-called "repless" model for orthopedic devices.
Repless sales not a magic bullet April 3, 2015 By Brad Perriello Leave a Comment There’s a lot of buzz these days about so-called "repless" sales models, in which hospitals buy generic medical devices without the benefit – or cost – of a traditional sales force.